Control Bionics (ASX: CBL) registers NeuroStrip with US FDA as commercial execution becomes the next test
Read More Pharma Industry News The factory is 60% empty. That may be exactly why Aurobindo Pharma (NSE: AUROPHARMA) wants it Read how Aurobindo Pharma plans to turn Lannett’s underused US factory, ADHD portfolio and CDMO platform into its next growth engine as policy shifts. byVenkateshJune 22, 2026